Your browser doesn't support javascript.
loading
A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus.
Ekhtiari, Hamed; Zare-Bidoky, Mehran; Sangchooli, Arshiya; Janes, Amy C; Kaufman, Marc J; Oliver, Jason A; Prisciandaro, James J; Wüstenberg, Torsten; Anton, Raymond F; Bach, Patrick; Baldacchino, Alex; Beck, Anne; Bjork, James M; Brewer, Judson; Childress, Anna Rose; Claus, Eric D; Courtney, Kelly E; Ebrahimi, Mohsen; Filbey, Francesca M; Ghahremani, Dara G; Azbari, Peyman Ghobadi; Goldstein, Rita Z; Goudriaan, Anna E; Grodin, Erica N; Hamilton, J Paul; Hanlon, Colleen A; Hassani-Abharian, Peyman; Heinz, Andreas; Joseph, Jane E; Kiefer, Falk; Zonoozi, Arash Khojasteh; Kober, Hedy; Kuplicki, Rayus; Li, Qiang; London, Edythe D; McClernon, Joseph; Noori, Hamid R; Owens, Max M; Paulus, Martin P; Perini, Irene; Potenza, Marc; Potvin, Stéphane; Ray, Lara; Schacht, Joseph P; Seo, Dongju; Sinha, Rajita; Smolka, Michael N; Spanagel, Rainer; Steele, Vaughn R; Stein, Elliot A.
Afiliação
  • Ekhtiari H; Laureate Institute for Brain Research, Tulsa, OK, USA. hekhtiari@laureateinstitute.org.
  • Zare-Bidoky M; Department of Psychiatry & Behavioral Sciences, University of Minnesota, Minneapolis, MN, USA. hekhtiari@laureateinstitute.org.
  • Sangchooli A; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.
  • Janes AC; Shahid-Sadoughi University of Medical Sciences, Yazd, Iran.
  • Kaufman MJ; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.
  • Oliver JA; Department of Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA, USA.
  • Prisciandaro JJ; Department of Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA, USA.
  • Wüstenberg T; Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA.
  • Anton RF; TSET Health Promotion Research Center, Stephenson Cancer Center, Oklahoma City, OK, USA.
  • Bach P; Department of Psychiatry & Behavioral Sciences, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA.
  • Baldacchino A; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.
  • Beck A; Department of Psychiatry and Neurosciences, Charité Campus Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Bjork JM; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.
  • Brewer J; Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health (CIMH), Heidelberg University, Mannheim, Germany.
  • Childress AR; Division of Population Studies and Behavioural Sciences, St Andrews University Medical School, University of St Andrews, Scotland, UK.
  • Claus ED; Department of Psychiatry and Neurosciences, Charité Campus Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Courtney KE; Faculty of Health, Health and Medical University, Campus Potsdam, Potsdam, Germany.
  • Ebrahimi M; Department of Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.
  • Filbey FM; Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, USA.
  • Ghahremani DG; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Azbari PG; Department of Biobehavioral Health, The Pennsylvania State University, University Park, PA, USA.
  • Goldstein RZ; Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA.
  • Goudriaan AE; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.
  • Grodin EN; Center for BrainHealth, School of Behavioral and Brain Sciences, University of Texas at Dallas, Dallas, TX, USA.
  • Hamilton JP; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA.
  • Hanlon CA; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.
  • Hassani-Abharian P; Department of Biomedical Engineering, Shahed University, Tehran, Iran.
  • Heinz A; Departments of Psychiatry & Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Joseph JE; Department of Psychiatry, Amsterdam University Medical Center, University of Amsterdam and Amsterdam Neuroscience, Amsterdam, The Netherlands.
  • Kiefer F; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA.
  • Zonoozi AK; Center for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Kober H; Center for Medical Image Science and Visualization, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Kuplicki R; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
  • Li Q; Brain and Cognition Clinic, Institute for Cognitive Science Studies, Tehran, Iran.
  • London ED; Department of Psychiatry and Neurosciences, Charité Campus Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • McClernon J; Department of Neuroscience, Medical University of South Carolina, Charleston, SC, USA.
  • Noori HR; Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health (CIMH), Heidelberg University, Mannheim, Germany.
  • Owens MM; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.
  • Paulus MP; Mashhad University of Medical Sciences, Mashhad, Iran.
  • Perini I; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Potenza M; Laureate Institute for Brain Research, Tulsa, OK, USA.
  • Potvin S; Department of Radiology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
  • Ray L; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA.
  • Schacht JP; Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA.
  • Seo D; International Center for Primate Brain Research, Center for Excellence in Brain Science and Intelligence Technology (CEBSIT)/Institute of Neuroscience (ION), Chinese Academy of Sciences, Shanghai, China.
  • Sinha R; McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Smolka MN; Department of Psychiatry, University of Vermont, Burlington, VT, USA.
  • Spanagel R; Laureate Institute for Brain Research, Tulsa, OK, USA.
  • Steele VR; Center for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Stein EA; Center for Medical Image Science and Visualization, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Nat Protoc ; 17(3): 567-595, 2022 03.
Article em En | MEDLINE | ID: mdl-35121856
ABSTRACT
Cue reactivity is one of the most frequently used paradigms in functional magnetic resonance imaging (fMRI) studies of substance use disorders (SUDs). Although there have been promising results elucidating the neurocognitive mechanisms of SUDs and SUD treatments, the interpretability and reproducibility of these studies is limited by incomplete reporting of participants' characteristics, task design, craving assessment, scanning preparation and analysis decisions in fMRI drug cue reactivity (FDCR) experiments. This hampers clinical translation, not least because systematic review and meta-analysis of published work are difficult. This consensus paper and Delphi study aims to outline the important methodological aspects of FDCR research, present structured recommendations for more comprehensive methods reporting and review the FDCR literature to assess the reporting of items that are deemed important. Forty-five FDCR scientists from around the world participated in this study. First, an initial checklist of items deemed important in FDCR studies was developed by several members of the Enhanced NeuroImaging Genetics through Meta-Analyses (ENIGMA) Addiction working group on the basis of a systematic review. Using a modified Delphi consensus method, all experts were asked to comment on, revise or add items to the initial checklist, and then to rate the importance of each item in subsequent rounds. The reporting status of the items in the final checklist was investigated in 108 recently published FDCR studies identified through a systematic review. By the final round, 38 items reached the consensus threshold and were classified under seven major categories 'Participants' Characteristics', 'General fMRI Information', 'General Task Information', 'Cue Information', 'Craving Assessment Inside Scanner', 'Craving Assessment Outside Scanner' and 'Pre- and Post-Scanning Considerations'. The review of the 108 FDCR papers revealed significant gaps in the reporting of the items considered important by the experts. For instance, whereas items in the 'General fMRI Information' category were reported in 90.5% of the reviewed papers, items in the 'Pre- and Post-Scanning Considerations' category were reported by only 44.7% of reviewed FDCR studies. Considering the notable and sometimes unexpected gaps in the reporting of items deemed to be important by experts in any FDCR study, the protocols could benefit from the adoption of reporting standards. This checklist, a living document to be updated as the field and its methods advance, can help improve experimental design, reporting and the widespread understanding of the FDCR protocols. This checklist can also provide a sample for developing consensus statements for protocols in other areas of task-based fMRI.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imageamento por Ressonância Magnética / Lista de Checagem Tipo de estudo: Guideline / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Nat Protoc Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imageamento por Ressonância Magnética / Lista de Checagem Tipo de estudo: Guideline / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Nat Protoc Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
...